New Zealand Begins HPV Vaccination Program For 50,000
This article was originally published in PharmAsia News
Executive Summary
New Zealand kicked off a program to provide free vaccinations against cervical cancer to 50,000 young women ages 17 and 18 years. Those taking advantage of the immunization program are to receive a human pappiloma virus vaccine. The program is to be expanded next year when the vaccine is made available to girls as young as 12, primarily through the nation's school system. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.